http://www.fpnotebook.com/
MisoprostolAka: Cytotec, PGE1 Gel
- Mechanism
- Gastric Mucosa Protection by prostaglandin replacement
- Preparations
- Misoprostol (Cytotec)
- Indication
- Peptic Ulcer Disease prevention
- Prevents ulcers in those on NSAIDs chronically
- Cervical Ripening agent in Pregnancy Labor Induction
- Dosing
- See Cervical Ripening for pregnancy dosing
- Option 1: 100 ug qid with food
- Option 2: 200 ug bid with food
- Better tolerated than qid dosing
- Side Effects
- Diarrhea
- Poorly tolerated
- Efficacy: Peptic Ulcer Disease reduction
- Dosing qid: 4% Peptic Ulcer Disease recurrence
- Dosing bid: 8% Peptic Ulcer Disease recurrence
- Placebo: 16% Peptic Ulcer Disease recurrence
- Reference
- Raskin (1995) Ann Intern Med 123:344
|
|---|
| Definition (MSH) | A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties. |
| Definition (NCI) | A radioprotective agent that belongs to the family of drugs called prostaglandins. |
| Concepts | Eicosanoid (T111)
, Pharmacologic Substance (T121)
|
| English | Misoprostol, MISOPROSTOL PREPARATION, Misoprostol product |
| Spanish | misoprostol |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
|
|---|
| Concepts | Eicosanoid (T111)
, Pharmacologic Substance (T121)
|
| English | Cytotec, Heumann Brand of Misoprostol, Misoprostol Heumann Brand, Misoprostol Pharmacia Brand, Misoprostol Searle Brand, Pharmacia Brand of Misoprostol, Pharmacia Spain Brand of Misoprostol, Searle Brand of Misoprostol |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
Navigation Tree